Ayala Pharmaceuticals Inc (ADXS)

[ubmmg]

As they decided to issue a secondary, this is a strong indication there are no monetary deals in the pipeline, nothing is expected for at least few months. That’s a reality.
This conference call will be crucial. Most likely, AXAL will be shelved. Otherwise, why this raise? No takers.
This is a bridge to something. What will it be? HOT monetization? NEO milestone payment? They need to extend the cash runway for few more months. It means they will raise $20M to $25M now. At what price? I wouldn’t be surprised to see the secondary priced at $1.05 or so. 20 million shares plus warrants. All depends on exercise price of the warrants. G-d, save us all.